Skip to main content
Equibles
PFHO logo

PFHO · Pacific Health Care Organization Inc · Metrics

Track PFHO — free

Use PFHO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PFHO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.94 +0.01 (+1.08%) At close · Oct 14
Rebalance outlook locked
Market Cap
$12.03M
Shares
12.80M
Volume · Oct 14 41.4K Avg daily vol (3M) 10.74K

PFHO metrics

80 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.94
Market cap
$12.03M

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
-6.0%
Price change (3M)
+13.3%
Price change (6M)
-21.7%
Price change (YTD)
-27.7%
Price change (1Y)
-30.4%
Trailing year
Price change (5Y)
+4.4%
52-week high
$1.39
52-week low
$0.80
Change from 52-week high
-32.4%
Change from 52-week low
+17.5%
Annualized volatility
95.9%
Annualized volatility (3M)
—
Beta
0.4
RSI (14D)
47.9
Price vs SMA 50
+3.9%
Price vs SMA 200
-12.3%
Avg volume (3M)
10,736
Relative volume
3.9
Average dollar volume
$9,852

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
12.80M

Valuation

12 metrics
P / E (TTM)
10.4
Trailing earnings · reciprocal yield 9.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 53.5%
P / book
0.9
reciprocal yield 113.0%
FCF yield
4.8%
TTM · current market cap
Buyback yield
0.0%
P / FCF
20.8
reciprocal yield 4.8%
P / operating cash flow
20.1
reciprocal yield 5.0%
Earnings yield
8.1%

Historical valuation

8 metrics
P / E historical average (3Y)
10.3×
reciprocal yield 9.7%
P / E historical average (5Y)
11.7×
reciprocal yield 8.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 117.2%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 118.5%
EV / EBIT historical average (3Y)
8.5×
reciprocal yield 11.8%
EV / EBIT historical average (5Y)
8.3×
reciprocal yield 12.1%
EV / EBITDA historical average (3Y)
7.9×
reciprocal yield 12.6%
EV / EBITDA historical average (5Y)
7.7×
reciprocal yield 13.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
14.4%
Trailing 12 months
Net margin
15.2%
Gross profit (TTM)
—
Operating profit (TTM)
$925,140
Net income (TTM)
$978,754
Trailing 12 months
Diluted EPS (TTM)
$0.09
FCF margin
9.0%
Effective tax rate
26.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$0.50
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.07
EBITDA per diluted share (TTM)
$0.07
Net income per diluted share (TTM)
$0.08
Operating cash flow per diluted share (TTM)
$0.05
Free cash flow per diluted share (TTM)
$0.05
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.02

Growth

11 metrics
Revenue growth YoY
+2.8%
Year over year
Net income growth YoY
-48.7%
Revenue (TTM)
$6.44M
Trailing 12 months
EPS growth YoY
-40.0%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+5.3%
Revenue CAGR (5Y)
+2.1%
EPS CAGR (3Y)
+40.1%
EPS CAGR (5Y)
+22.4%
FCF CAGR (3Y)
+19.2%
FCF CAGR (5Y)
+4.0%

Quality

14 metrics
Return on equity
7.2%
Return on assets
6.9%
Debt / equity
—
Current ratio
27.2
EBITDA (TTM)
$946,394
Free cash flow (TTM)
$578,446
Quick ratio
27.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.24M
Total assets
$14.11M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$597,739
Capital expenditures (TTM)
$19,293
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
17 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1138476 CUSIP 69439P407 Visit website Investor relations